ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 109 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2016. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $9,742,000 | +19.0% | 210,500 | -9.2% | 0.13% | +21.1% |
| Q1 2017 | $8,185,000 | +541.0% | 231,800 | +127.3% | 0.11% | +581.2% |
| Q4 2016 | $1,277,000 | -9.6% | 102,000 | 0.0% | 0.02% | +6.7% |
| Q3 2016 | $1,413,000 | +40.2% | 102,000 | 0.0% | 0.02% | +50.0% |
| Q2 2016 | $1,008,000 | -41.6% | 102,000 | 0.0% | 0.01% | -23.1% |
| Q1 2016 | $1,725,000 | +244.3% | 102,000 | +353.3% | 0.01% | +333.3% |
| Q4 2015 | $501,000 | – | 22,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,679,835 | $69,675,000 | 19.39% |
| Endurant Capital Management LP | 207,293 | $5,390,000 | 1.94% |
| Bellevue Group AG | 5,138,451 | $133,599,000 | 1.53% |
| Rhenman & Partners Asset Management AB | 592,225 | $15,398,000 | 1.26% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,562,869 | $40,635,000 | 0.93% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 31,434 | $817,000 | 0.62% |
| WASATCH ADVISORS LP | 3,998,010 | $103,949,000 | 0.51% |
| HAMILTON LANE ADVISORS LLC | 46,181 | $1,201,000 | 0.45% |
| Boxer Capital, LLC | 500,000 | $13,000,000 | 0.42% |
| DCF Advisers, LLC | 38,500 | $1,001,000 | 0.41% |